Glass Jacobson Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.5K Hold
470
0.01% 404
2026
Q1
$17.3K Hold
470
0.01% 424
2025
Q4
$23.9K Buy
470
+100
+27% +$5.11K 0.01% 388
2025
Q3
$20.5K Hold
370
0.01% 395
2025
Q2
$25.5K Sell
370
-40
-10% -$2.72K 0.01% 359
2025
Q1
$35.3K Hold
410
0.01% 424
2024
Q4
$35.3K Sell
410
-2,784
-87% -$301K 0.01% 424
2024
Q3
$380K Buy
3,194
+543
+20% +$72.4K 0.13% 167
2024
Q2
$378K Sell
2,651
-560
-17% -$74.2K 0.14% 162
2024
Q1
$412K Hold
3,211
0.15% 146
2023
Q4
$332K Buy
3,211
+211
+7% +$20.9K 0.14% 161
2023
Q3
$273K Buy
3,000
+960
+47% +$84.6K 0.13% 172
2023
Q2
$165K Buy
+2,040
New +$167K 0.08% 209
2022
Q4
$61K Buy
+902
New +$52.9K 0.03% 319

Other funds holding NVO

Glass Jacobson Investment Advisors's NVO Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 470 shares worth $22.5K. The position accounts for 0.01% of the portfolio, ranked #404.

Glass Jacobson Investment Advisors first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $412K in Q1 2024. 712 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Glass Jacobson Investment Advisors held 470 shares of Novo Nordisk worth $22.5K as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #404 holding.
  • Glass Jacobson Investment Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's Novo Nordisk position peaked at $412K in Q1 2024.
  • 712 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.